Investigator
Sanjay K Jain
CINCINNATI CHILDRENS HOSP MED CTR · funded by NIAID
- Companies
- 1
- Grants
- 4
- Non-dilutive funding
- $5.3M
- First award
- Feb 24, 2025
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Aug 1, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- Boston Scientific Corporation74momentum
OncologyGrant-onlyListed · BSX
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Animal Models to Develop New Regimens for S. aureus Implant-Associated Infections
$3.3MAug 1, 2025NIAIDCINCINNATI CHILDRENS HOSP MED CTRNIH RePORTER · 11446824 (opens the source filing in a new tab)
- R21
PET to Assess Post-TB Lung Disease in TB Patients with / without HIV coinfection
$446kJul 1, 2025NIAIDCINCINNATI CHILDRENS HOSP MED CTRNIH RePORTER · 11445100 (opens the source filing in a new tab)
- R01
Pro-apoptotic Drugs as Host-Directed Treatments for Pulmonary Tuberculosis
$775kFeb 24, 2025NIAIDJOHNS HOPKINS UNIVERSITYNIH RePORTER · 11101929 (opens the source filing in a new tab)
- R01
Pro-apoptotic Drugs as Host-Directed Treatments for Pulmonary Tuberculosis”
$810kFeb 24, 2025NIAIDCINCINNATI CHILDRENS HOSP MED CTRNIH RePORTER · 11452554 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources